Insulin-like growth factors (IGF)-I and -II and IGF binding protein-1, -2, and -3 in patients with acromegaly before and after adenomectomy
- PMID: 7513781
- DOI: 10.1016/0026-0495(94)90199-6
Insulin-like growth factors (IGF)-I and -II and IGF binding protein-1, -2, and -3 in patients with acromegaly before and after adenomectomy
Abstract
The interrelationship between insulin-like growth factors (IGFs) and their major binding proteins (IGFBPs) as a function of disease activity in acromegaly has not previously been prospectively evaluated. We studied basal and insulin-stimulated serum levels of IGF-I and -II and IGFBP-1, -2, and -3 in six acromegalic patients before and 2 months after successful adenomectomy compared with a group of sex- and age-matched healthy, untreated subjects. All were studied postabsorptively (11 AM) and at the end of a 2-hour euglycemic glucose clamp (0.4 mU insulin/kg x min). Serum IGF-I levels (mean +/- SE) were elevated in acromegaly but were normalized following therapy (basal state IGF-I [micrograms/L], 857 +/- 119 [active] v 255 +/- 65 [postoperative] v 190 +/- 20 [control]). Serum IGF-II levels did not change following therapy and were similar to those of the control group. IGF levels did not change during the clamp. Serum IGFBP-3 levels were elevated in active acromegaly, but were normalized after therapy (basal state IGFBP-3 [micrograms/L] 6,983 +/- 612 [active] v 3,939 +/- 504 [postop] v 3,358 +/- 125 [control]). The molar ratio of (IGF-I+IGF-II): IGFBP-3 was similar in all studies. Serum IGFBP-1 interacted significantly with time in all studies, exhibiting a gradual decrease in the basal state and ensued by further suppression during the clamp. Insulin and IGFBP-1 correlated inversely in the pooled data and in the acromegalic patients.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.Clin Endocrinol (Oxf). 1994 Jul;41(1):85-93. doi: 10.1111/j.1365-2265.1994.tb03788.x. Clin Endocrinol (Oxf). 1994. PMID: 7519529
-
Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.J Clin Endocrinol Metab. 2001 Mar;86(3):1091-8. doi: 10.1210/jcem.86.3.7288. J Clin Endocrinol Metab. 2001. PMID: 11238491
-
Insulin-like growth factors (IGF) I and II and IGF binding proteins 1, 2 and 3 during low-dose growth hormone (GH) infusion and sequential euglycemic and hypoglycemic glucose clamps: studies in GH-deficient patients.Acta Endocrinol (Copenh). 1993 Jun;128(6):513-20. doi: 10.1530/acta.0.1280513. Acta Endocrinol (Copenh). 1993. PMID: 7687807 Clinical Trial.
-
Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.J Clin Endocrinol Metab. 1995 Mar;80(3):927-32. doi: 10.1210/jcem.80.3.7533774. J Clin Endocrinol Metab. 1995. PMID: 7533774
-
IGF binding proteins and their functions.Mol Reprod Dev. 1993 Aug;35(4):368-74; discussion 374-5. doi: 10.1002/mrd.1080350409. Mol Reprod Dev. 1993. PMID: 7691098 Review.
Cited by
-
Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation.J Clin Lab Anal. 1999;13(4):166-72. doi: 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.0.CO;2-X. J Clin Lab Anal. 1999. PMID: 10414596 Free PMC article.
-
Hepatocellular carcinoma: Where there is unmet need.Mol Oncol. 2015 Oct;9(8):1501-9. doi: 10.1016/j.molonc.2015.06.005. Epub 2015 Jun 25. Mol Oncol. 2015. PMID: 26160430 Free PMC article. Review.
-
Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.J Endocrinol Invest. 1999 Feb;22(2):98-103. doi: 10.1007/BF03350887. J Endocrinol Invest. 1999. PMID: 10195375
-
Somatostatin analogue treatment of neuroendocrine tumours.Postgrad Med J. 1996 Jul;72(849):403-8. doi: 10.1136/pgmj.72.849.403. Postgrad Med J. 1996. PMID: 8935599 Free PMC article. Review.
-
Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.J Endocrinol Invest. 1996 Sep;19(8):548-55. doi: 10.1007/BF03349015. J Endocrinol Invest. 1996. PMID: 8905479 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous